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Mammalian target of rapamycin (mTOR), also known as mechanistic target of rapamycin, is a 
known metabolic master-switch. In conditions of starvation, mTOR suppresses biosynthetic 
programs and increases the recycling of proteins and organelles. Upon stimulation by nutrients 
and growth factors, however, mTOR causes activation of biosynthesis and suppression of 
autophagy. The mTOR-centered molecular pathway is a major pathway of growth regulation 
and metabolism, linked to aging and the development of cancer, obesity, type 2 diabetes, 
neurodevelopmental and neurodegenerative diseases. Currently, the role of environmental 
factors in the modulation of the mTOR pathway remains largely unknown. The present study 
suggests that perinatal exposure to environmentally-relevant doses of polybrominated diphenyl 
ethers (PBDEs), a group of ubiquitous flame-retardants, results in long-lasting reprogramming of 
the mTOR pathway in mouse liver. This reprogramming includes suppression of mTORC1 and 
mTORC2 activity, accompanied by coordinated up-regulation of protein synthesis machinery 
and increased concentrations of circulating IGF-1. Further, experiments with MCF-7 breast 
cancer cells demonstrate that exposure to PBDEs results in fast induction of the REDD1/DDIT4 
gene – a potent suppressor of mTORC1. This data indicates that the response of liver tissue to 
PBDE exposure during this critical developmental window is a dynamic process, and is likely 
triggered via a REDD1-dependent mechanism, ultimately resulting in long-lasting changes in the 
metabolic profile of the tissue. This study suggests that environmental exposures to brominated 
flame retardants may have profound and long-term effects on the central regulation hub of 
metabolic health, and may be implicated in the pathogenesis of the most relevant diseases of 
modern society. 
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